Danda Trouve Investment Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Danda Trouve Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $2,391 - $3,039	-5 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$544.75 - $658.21 $13,618 - $16,455	-25 Reduced 83.33%	5 $3,000
Q2 2020 Aug 03, 2020	SELL	$493.32 - $643.92 $4,933 - $6,439	-10 Reduced 25.0%	30 $19,000
Q1 2020 Apr 22, 2020	BUY	$336.18 - $494.43 $13,447 - $19,777	40 New	40 $20,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Danda Trouve Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Danda Trouve Investment Management, Inc. with notifications on news.